Eli Lilly and Company

Patent Owner

Follow Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 517 19
 
 
C07D HETEROCYCLIC COMPOUNDS 320 15
 
 
C07K PEPTIDES 100 36
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 63 33
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 51 85
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 46 109
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 42 80
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 41 40
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 34 68
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 63
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0010,573 IL-17 ANTIBODY FORMULATION Mar 01, 13 Jan 08, 15 [C07K]
2015/0005,305 NOVEL MORPHOLINYL DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS Jan 24, 13 Jan 01, 15 [C07D, C07C]
2014/0369,989 METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE Feb 07, 13 Dec 18, 14 [C12N, A23K]
2014/0371,212 BACE INHIBITORS Jun 11, 14 Dec 18, 14 [C07D]
2014/0371,269 PHENYL METHANESULFONAMIDE DERIVATIVES USEFUL AS MGAT-2 INHIBITORS Jan 16, 13 Dec 18, 14 [C07D]
2014/0357,664 3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS May 27, 14 Dec 04, 14 [C07D]
2014/0349,310 Anti-c-Met Antibodies Sep 13, 12 Nov 27, 14 [G01N]
2014/0343,151 LEUKOTRIENE B4 ANTAGONIST COMPOUND Jan 04, 13 Nov 20, 14 [C07C]
2014/0335,096 ANTI-GLUCAGON ANTIBODIES AND USES THEREOF Nov 27, 12 Nov 13, 14 [G01N, C07K]
2014/0324,021 MEDICINAL PATCH AND INJECTOR SYSTEM Nov 07, 12 Oct 30, 14 [A61M]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,932,557 Imaging agents for detecting neurological dysfunction May 22, 12 Jan 13, 15 [A61M, C07D, C07B, A61K]
8,933,098 Dimethyl-benzoic acid compounds Dec 04, 13 Jan 13, 15 [C07D, A61K]
8,927,492 Fibroblast growth factor 21 proteins Apr 23, 14 Jan 06, 15 [A61K, C07K]
8,921,327 Ectoparasiticidal methods and formulations Nov 07, 13 Dec 30, 14 [A01N, A61K]
8,889,710 Parasiticidal dihydroisoxazole compounds Dec 20, 13 Nov 18, 14 [A01N, C07D, A61K]
8,889,856 Tetrahydropyrrolothiazine compounds May 22, 14 Nov 18, 14 [C07D, A61K]
8,883,726 Fibroblast growth factor 21 variants Aug 13, 13 Nov 11, 14 [A61K, C07K]
8,871,727 Ectoparasiticidal methods and formulations Jun 16, 10 Oct 28, 14 [A01N, A61K]
8,864,721 Gearing mechanism for a dose delivery device Sep 23, 11 Oct 21, 14 [A61M]
8,862,481 Method and system for collecting, managing and reporting feedlot data and feed additive consumption data Jun 29, 07 Oct 14, 14 [A01K, G06Q, A23K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA Oct 28, 10 Nov 22, 12 [A61P, A61K]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT May 27, 10 Sep 13, 12 [A61P, A61K]
2012/0195,904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES Apr 11, 12 Aug 02, 12 [A61P, A61K]
2012/0172,422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid Mar 13, 12 Jul 05, 12 [A61P, A61K]
2012/0071,490 P70 S6 KINASE INHIBITORS Nov 30, 11 Mar 22, 12 [C07D, A61P, A61K]
2012/0022,140 Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel Sep 28, 11 Jan 26, 12 [A61P, A61K]
2011/0294,792 PURINE DERIVATIVES AS KINASE INHIBITORS Aug 09, 11 Dec 01, 11 [C07D, A61P, A61K]
2011/0287,019 THERAPEUTIC TARGETING OF ESCORT PROTEINS Jun 13, 11 Nov 24, 11 [A61P, A61K, C07K]
2011/0288,032 ENZASTAURIN FOR THE TREATMENT OF CANCER Dec 07, 09 Nov 24, 11 [A61P, A61K]
2011/0212,092 GLUCAGON RECEPTOR ANTAGONISTS May 16, 11 Sep 01, 11 [A61P, A61K, C07K]
2011/0212,977 P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY Nov 04, 09 Sep 01, 11 [A61P, A61K]
2011/0207,670 COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS Oct 21, 09 Aug 25, 11 [A61P, A61K, C07K]
2011/0177,195 ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS Mar 25, 11 Jul 21, 11 [A23K]
2011/0105,392 Pegylated Insulin Lispro Compounds Jun 09, 09 May 05, 11 [A61P, A61K, C07K]
2011/0034,373 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY Jul 30, 08 Feb 10, 11 [A61P, A61K]
2011/0034,511 SUBSTITUTED 2-CARBONYLAMINO-6-PIPERIDINAMINOPYRIDINES AND SUBSTITUTED 1-CARBONYLAMINO-3-PIPERIDINAMINOBENZENES AS 5-HT1F AGONISTS Sep 28, 10 Feb 10, 11 [C07D, A61P, A61K]
2010/0324,140 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Aug 26, 10 Dec 23, 10 [A61P, C07C, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL